Abstract Background We previously reported that, among all the naturally occurring amino acids, l-valine is the most powerful luminal stimulator of glucagon-like peptide 1 (GLP-1) release from the upper part of the rat small intestine
However, it never received FDA approval because the results, while positive, weren't dramatic enough to meet regulatory thresholds for an obesity drug
Global Weight Loss Drugs Market Segmentation 1) By Type: Liquid, Tablets, Capsules 2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy 3) By Application: Weight-Reducing Aid, Fat Absorption Inhibitors, Metabolic Boosters Subsegments: 1) By Liquid: Syrups, Solutions, Suspensions 2) By Tablets: Immediate-Release Tablets, Extended-Release Tablets 3) By Capsules: Hard Capsules, Softgel Capsules What Is The Driver Of The Weight Loss Drugs Market
Step 3: Review together at consultation
[PubMed: 22631062] 94